The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: A systematic review of novel technologies

Journal of Urology

Volumn 191, Issue 6, 2014, Pages 1655-1664

  Richards, Kyle A ^a   Smith, Norm D ^a   Steinberg, Gary D ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

operative; surgical procedures; urinary bladder neoplasms

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEPHALOSPORIN; MITOMYCIN; PROTOPORPHYRIN;

ANTIBIOTIC PROPHYLAXIS; BLADDER PERFORATION; BLADDER SURGERY; CANCER GROWTH; CANCER RECURRENCE; CAUTERIZATION; COCHRANE LIBRARY; CYSTOSCOPY; EVIDENCE BASED PRACTICE; FLUORESCENCE CYSTOSCOPY; GENERAL ANESTHESIA; HUMAN; MEDLINE; NARROW BAND IMAGING; NON MUSCLE INVASIVE BLADDER CANCER; OPTICAL COHERENCE TOMOGRAPHY; PARALYSIS; PEROPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TRANSURETHRAL BLADDER TUMOR RESECTION; TREATMENT DURATION; WHITE LIGHT; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; PATHOLOGY; PROCEDURES; TUMOR INVASION; URETHRA; URINARY BLADDER NEOPLASMS; UROLOGIC SURGERY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; DISEASE COURSE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PERIOPERATIVE PERIOD; PERSONAL EXPERIENCE; PHOTODYNAMICS; RECURRENCE RISK; RECURRENT DISEASE; REGIONAL ANESTHESIA; TASK PERFORMANCE; TRANSURETHRAL RESECTION;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; CYSTOSCOPY; HUMANS; NEOPLASM INVASIVENESS; URETHRA; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 84900451259     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.01.087     Document Type: Review

References (49)

1. R. Siegel, C. DeSantis, and K. Virgo et al. Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 62 2012 220
2. O. Shahin, G.N. Thalmann, and C. Rentsch et al. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival J Urol 169 2003 96
3. E.B. Avritscher, C.D. Cooksley, and H.B. Grossman et al. Clinical model of lifetime cost of treating bladder cancer and associated complications Urology 68 2006 549
4. D. Moher, A. Liberati, and J. Tetzlaff et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2010 336
5. D. Moher, K.F. Schulz, and D.G. Altman The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials Lancet 357 2001 1191
6. P.M. Bossuyt, J.B. Reitsma, and D.E. Bruns et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative BMJ 326 2003 41
7. M. Brausi, J.A. Witjes, and D. Lamm et al. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group J Urol 186 2011 2158
8. M. Burger, W. Oosterlinck, and B. Konety et al. ICUD-EAU International Consultation on Bladder Cancer 2012: non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 63 2013 36
9. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Bladder Cancer, Version 1.2013. Available at www.nccn.org. Accessed July 3, 2013.
10. K.T. Adiyat, D. Katkoori, and C.T. Soloway et al. "Complete transurethral resection of bladder tumor": are the guidelines being followed? Urology 75 2010 365
11. J. Huang, J. Fu, and H. Zhan et al. Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor Urol Int 89 2012 319
12. P. Mariappan, S.M. Finney, and E. Head et al. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking BJU Int 109 2012 1666
13. M. Rouprêt, D.R. Yates, and J. Varinot et al. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience Can J Urol 19 2012 6459
14. M. Richterstetter, B. Wullich, and K. Amann et al. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer BJU Int 110 2012 E76
15. S. Kruck, J. Bedke, and J. Hennenlotter et al. Virtual bladder tumor transurethral resection: an objective evaluation tool to overcome learning curves with and without photodynamic diagnostics Urol Int 87 2011 138
16. S. Xishuang, Y. Deyong, and C. Xiangyu et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer J Endourol 24 2010 69
17. S.H. Lee, C.W. Jeong, and H.J. Lee et al. Ultrasound guided obturator nerve block: a single interfascial injection technique J Anesth 25 2011 923
18. M. Khorrami, M. Hadi, and A. Javid et al. A comparison between blind and nerve stimulation guided obturator nerve block in transurethral resection of bladder tumor J Endourol 26 2012 1319
19. J.S. Wolf Jr., C.J. Bennett, and R.R. Dmochowski et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis J Urol 179 2008 1379
20. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Available at http://circ.ahajournals.org/content/116/15/1736. Accessed November 2013.
21. P. Puppo, F. Bertolotto, and C. Introini et al. Bipolar transurethral resection in saline (TURis): outcome and complication rates after the first 1000 cases J Endourol 23 2009 1145
22. N.P. Gupta, A.K. Saini, and P.N. Dogra et al. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience BJU Int 108 2011 553
23. D.J. Canter, K. Ogan, and V.A. Master Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors Can J Urol 19 2012 6211
24. W. Tao, D. Yang, and Y. Shan et al. Safety and efficacy of 120W high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer J Xray Sci Technol 21 2013 309
25. S. Mirza, S. Panesar, and K.J. AuYong et al. The effects of irrigation fluid on core temperature in endoscopic urological surgery J Perioper Pract 17 2007 494
26. R.J. Sylvester, A.P. van der Meijden, and W. Oosterlinck et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466
27. Y. Fradet, H.B. Grossman, and L. Gomella et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study J Urol 178 2007 68
28. M.C. Schumacher, S. Holmäng, and T. Davidsson et al. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study Eur Urol 57 2010 293
29. A. Stenzl, M. Burger, and Y. Fradet et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer J Urol 184 2010 1907
30. H.B. Grossman, A. Stenzl, and Y. Fradet et al. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy J Urol 188 2012 58
31. M. Burger, H.B. Grossman, and M. Droller et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data Eur Urol 64 2013 846
32. S.S. Garfield, M.B. Gavaghan, and S.O. Armstrong et al. The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United Sates projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation Can J Urol 20 2013 6682
33. E.R. Ray, K. Chatterton, and M.S. Khan et al. Hexaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin BJU Int 105 2010 789
34. H.H. Herr Narrow band imaging cystoscopy Urol Oncol 29 2011 353
35. K. Li, T. Lin, and X. Fan et al. Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis Int J Urol 20 2013 602
36. B. Geavlete, R. Multescu, and D. Georgescu et al. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors-results of a prospective, randomized comparison to the standard approach Urology 79 2012 846
37. I. Bala, N. Bharti, and V.K. Chaubey et al. Efficacy of gabapentin for prevention of postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor Urology 79 2012 853
38. R.J. Sylvester, W. Oosterlinck, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186
39. N. Perlis, A.R. Zlotta, and J. Beyene et al. Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review Eur Urol 64 2013 421
40. S.M. Di Stasi, M. Valenti, and C. Verri et al. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial Lancet Oncol 12 2011 871
41. F.N. Burks, A.B. Liu, and R.S. Suh et al. Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer J Urol 188 2012 2108
42. L.S. Mertens, W. Meinhardt, and W.B. Rier et al. Extravasation of intravesical chemotherapy for non-muscle-invasive bladder cancer Urol Int 89 2012 332
43. B.K. Hollenbeck, D.C. Miller, and D. Taub et al. Risk factors for adverse outcomes after transurethral resection of bladder tumors Cancer 106 2006 1527
44. H.W. Herr Role of re-resection in non-muscle-invasive bladder cancer ScientificWorldJournal 11 2011 283
45. R.T. Divrik, A.F. Sahin, and U. Yildirim et al. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial Eur Urol 58 2010 185
46. A. Lopez-Beltran, F. Algaba, and D.M. Berney et al. Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP) Histopathology 58 2011 579
47. H. Ren, K.C. Park, and R. Pan et al. Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography J Urol 187 2012 1063
48. Y.T. Pan, Z.L. Wu, and Z.J. Yuan et al. Subcellular imaging of epithelium with time-elapse optical coherence tomography J Biomed Opt 12 2007 050504
49. Z. Yuan, B. Chen, and H. Ren et al. On the possibility of time-lapse ultrahigh-resolution optical coherence tomography for bladder cancer grading J Biomed Opt 14 2009 050502